Healthcare Pricing Issues
The discussion highlights the potential of GLP-1 drugs not only in obesity management but also in regulating pleasure from food and substances like alcohol. The current U.S. healthcare pricing model is criticized for being unsustainable, especially when compared to other developed nations. The need for long-term studies to assess safety and economic viability of these drugs is emphasized, as is the reality that discontinuing them often leads to weight regain.In this clip
From this podcast
The Prof G Pod with Scott Galloway
Conversation with Dr. Peter Attia — The Pillars of Healthspan and Longevity
Related Questions